BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2098263)

  • 1. [Anti-islet antibodies: methods for their determination and etiopathogenetic importance].
    Velinov M
    Eksp Med Morfol; 1990; 29(4):62-5. PubMed ID: 2098263
    [No Abstract]   [Full Text] [Related]  

  • 2. Islet autoimmunity and genetic mutations in Chinese subjects initially thought to have Type 1B diabetes.
    Zhang D; Zhou Z; Li L; Weng J; Huang G; Jing P; Zhang C; Peng J; Xiu L
    Diabet Med; 2006 Jan; 23(1):67-71. PubMed ID: 16409568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
    Bergerot I; Souchier C; Thivolet C
    C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is antigen specificity of autoreactive T cells the key to islet entry?
    Penaranda C; Bluestone JA
    Immunity; 2009 Oct; 31(4):534-6. PubMed ID: 19833083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of islet cell antibodies in the pathogenesis of type I diabetes.
    Brogren CH; Baekkeskov S; Dyrberg T; Lernmark A; Marner B; Nerup J; Papadopoulos GK
    Curr Probl Clin Biochem; 1983; 12():65-85. PubMed ID: 6360543
    [No Abstract]   [Full Text] [Related]  

  • 6. beta-Cell death during progression to diabetes.
    Mathis D; Vence L; Benoist C
    Nature; 2001 Dec; 414(6865):792-8. PubMed ID: 11742411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus.
    Muir A; Schatz DA; Maclaren NK
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of insulin-dependent diabetes mellitus.
    Atkinson MA; Maclaren NK
    N Engl J Med; 1994 Nov; 331(21):1428-36. PubMed ID: 7969282
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes].
    Bieg S; Seissler J; Scherbaum WA
    Med Klin (Munich); 1995 Oct; 90(10):594-8. PubMed ID: 7500923
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinico-immunologic aspects of diabetes mellitus].
    Esenin VI; Zlobina EN; Demin IuM; Dedov II
    Sov Med; 1990; (3):100-1. PubMed ID: 2195666
    [No Abstract]   [Full Text] [Related]  

  • 14. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 15. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
    Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
    J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
    [No Abstract]   [Full Text] [Related]  

  • 16. Islet cell autoimmunity in women with gestational diabetes and risk of progression to insulin-dependent diabetes mellitus.
    Mauricio D; Balsells M; Morales J; Corcoy R; Puig-Domingo M; de Leiva A
    Diabetes Metab Rev; 1996 Dec; 12(4):275-85. PubMed ID: 9013072
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoantibodies to pancreatic islet cells and insulin in IDDM families: the GAW5 data.
    Maclaren NK; Riley WJ; McCulloch DK; Palmer JP
    Genet Epidemiol; 1989; 6(1):39-41. PubMed ID: 2659429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibodies to the pancreatic islet cells in type-1 diabetes mellitus].
    Zlobina EN; Esenin VI; Demin IuM; Minkin SA
    Sov Med; 1988; (12):21-3. PubMed ID: 2468188
    [No Abstract]   [Full Text] [Related]  

  • 20. [Islet cell antibodies in children with diabetes in Sweden--a preliminary report].
    Landin M; Sundkvist G; Lernmark A; Dahlquist G; Blom L; Sandström A; Nyström L; Wall S
    Lakartidningen; 1987 Jun; 84(23):2038-40. PubMed ID: 3309511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.